Those suffering from epilepsy can benefit greatly from the cannabis compound
Epilepsy affects 1.5% of the world’s population. One-third of this population suffers from what is known as refractory or treatment-resistant epilepsy, a type that does not respond to conventional treatments. However, the cannabis compound cannabidiol (CBD), which has been tested as a treatment for difficult-to-treat epilepsy, has shown promising results. Consuming CBD reduces seizures by half in some people suffering from epilepsy and improves sleep quality, as confirmed by a recent study.
After having consumed CBD products constantly, better tolerance to epilepsy medications was also reported in different patients, as they apparently used fewer prescription drugs in general, and psychiatric symptoms such as anxiety were greatly reduced. “These findings further emphasize the need for controlled research to determine the optimal types of CBD products, dosages, and concomitant use of other medications that maximize potential clinical benefits and minimize potential risks,” the report says.
In recent years, there has been growing interest related to the use of medical cannabis for the treatment of different diseases, including epilepsy. We now know that cannabis plants contain more than 100 terpenophenolic compounds that have been termed cannabinoids. CBD has undoubtedly demonstrated why it is one of the most relevant so far.
Different preclinical models of epilepsy have shown that this cannabinoid has anticonvulsant properties, so it has begun to use 100% purified cannabidiol and cannabis extracts enriched with cannabidiol for the treatment of epilepsy in humans. The efficacy and safety of these products have been demonstrated in different open studies and randomized controlled clinical trials.